Get started
Author

Ahmed Alkhodri Ahmed Alkhodri

Observed names: A. Alkhodri, Ahmed Alhodri, Ahmed Alkhodri, Аhmed Alkhodri, Алходри А.
ORCID: 0000-0001-5215-1079
Observed ORCID: 0000-0001-5215-1079
OpenAlex ID: A5086568900
Preparation, Evaluation and Development Celecoxib Prolonged Release (PR) Tablets by using Cellulose Polyacrylic acid – based polymers
2022 · Svetlana Suslina, Аhmed Alkhodri · Research Journal of Pharmacy and Technology · 3
Development of Celecoxib Granules for Manufacturing of Prolonged Release Celecoxib Capsules and Tablets
2022 · A. Alkhodri, S. N. Suslina · Drug development & registration · 3
PDF
Preparation, Development and Analytical Evaluation of Solid Pharmaceutical Dosage Forms of Nimesulide with Controlled Release and Immediately Release
2025 · Ahmed Alkhodri, Shoeb Alahmad, et al. · Research Journal of Pharmacy and Technology · 1
Preparation, Evaluation and Development Trimetazidine Dihydrochloride Extended Release (ER) Tablets by Wet Granulation Method
2026 · Ahmed Alkhodri · Research Journal of Pharmacy and Technology
Разработка И Валидация Методики Количественного Определения Целекоксиба В Таблетках Методом Уф-спектрофотометрии
2022 · Алходри А., Александрова Е.Ю., et al. · Вопросы обеспечения качества лекарственных средств
PDF
Stability study of Celecoxib tablets 200 mg and Celecoxib sustained release tablets 200 mg by quality indicators during storage
2022 · Ahmed Alkhodri Ahmed Alkhodri, Svetlana N. Suslina
Features and analysis of the current problems with the use of NSAIDs in the Arab countries
2021 · Ahmed Alhodri, Alfia Nailevna Ibragimova, et al. · Farmaciya (Pharmacy)
Works count: 7
Citation count: 7
H-index: 2
I10-index:
Year
Topic
Type